Quality of life issues in elderly acute myeloid leukemia patients
Quality of life issues in elderly acute myeloid leukemia patients
About this item
Full title
Author / Creator
Publisher
London: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
The median age of acute myeloid leukemia (AML) is 70 years. Treatment approaches include standard chemotherapy, palliative chemotherapy and investigational agents, depending upon disease biology and patient factors. In this article, we highlight the issues involved in the treatment of AML in older patients, focusing on the quality of life changes a...
Alternative Titles
Full title
Quality of life issues in elderly acute myeloid leukemia patients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_883226473
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_883226473
Other Identifiers
ISSN
1745-509X
E-ISSN
1745-5103
DOI
10.2217/ahe.11.32
